| scholarly article | Q13442814 |
| P50 | author | Koji Fukui | Q55873512 |
| Donald K. Ingram | Q107733297 | ||
| P2093 | author name string | Rafael de Cabo | |
| Joanne S Allard | |||
| Evelyn J Perez | |||
| Priscilla Carpenter | |||
| P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
| Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle | Q22241966 | ||
| The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex | Q27319458 | ||
| Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice | Q28485110 | ||
| Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner | Q28539904 | ||
| Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription | Q29617066 | ||
| IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 | Q29620059 | ||
| Metabolic syndrome is associated with learning and recall impairment in middle age. | Q33928071 | ||
| Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation | Q34032680 | ||
| Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats | Q34065151 | ||
| Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus | Q34095221 | ||
| Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity | Q34131805 | ||
| Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin | Q34157227 | ||
| Metformin improves healthspan and lifespan in mice | Q34360789 | ||
| Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? | Q34608998 | ||
| Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study | Q34658239 | ||
| Metformin--mode of action and clinical implications for diabetes and cancer | Q34658712 | ||
| If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. | Q34852281 | ||
| Correlation of mRNA and protein in complex biological samples. | Q35009100 | ||
| Regulation of Nrf2 signaling and longevity in naturally long-lived rodents | Q35229453 | ||
| Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status | Q35534198 | ||
| Intracerebroventricular injection of metformin induces anorexia in rats | Q36191735 | ||
| Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. | Q37129434 | ||
| Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology | Q37178970 | ||
| Increased risk of cognitive impairment in patients with diabetes is associated with metformin | Q37193677 | ||
| Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials | Q37493220 | ||
| Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia | Q38181823 | ||
| NGF, BDNF, NT3, and NT4. | Q38199407 | ||
| BDNF and synaptic plasticity, cognitive function, and dysfunction | Q38199414 | ||
| Effects of metformin on weight loss: potential mechanisms. | Q38238203 | ||
| Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study | Q38433563 | ||
| Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. | Q38464449 | ||
| Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress. | Q38479656 | ||
| Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation. | Q38975999 | ||
| Metformin and intestinal glucose handling | Q40927868 | ||
| Relationship between body fat mass, carbohydrate tolerance and iri response during glucose infusion in subjects with early diabetes | Q41658865 | ||
| Metformin directly acts on mitochondria to alter cellular bioenergetics. | Q41897802 | ||
| Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update | Q42253351 | ||
| Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice | Q42705749 | ||
| Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide | Q42794498 | ||
| Metformin improves liver antioxidant potential in rats fed a high-fructose diet | Q44258311 | ||
| Lean mass inversely predicts plasma glucose levels after oral glucose load independent of insulin secretion or insulin sensitivity in glucose intolerance subjects | Q45841055 | ||
| Improving metabolic control leads to better working memory in adults with type 2 diabetes. | Q46917184 | ||
| Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects | Q46926316 | ||
| Central administration of metformin into the third ventricle of C57BL/6 mice decreases meal size and number and activates hypothalamic S6 kinase | Q47225253 | ||
| The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression | Q48266485 | ||
| A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin | Q48407108 | ||
| R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia | Q48541090 | ||
| Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia | Q48575097 | ||
| Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice | Q48613553 | ||
| The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats | Q48665393 | ||
| Social deprivation stress is a triggering factor for the emergence of anxiety- and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice | Q48860107 | ||
| Metformin treatment alters memory function in a mouse model of Alzheimer's disease. | Q50636567 | ||
| Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. | Q51748258 | ||
| Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. | Q52120884 | ||
| Decreased cognitive function in aging non-insulin-dependent diabetic patients. | Q52209256 | ||
| Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1α pathway. | Q54383877 | ||
| [Absorption, distribution in the organism and elimination of metformin] | Q71262502 | ||
| Accumulation of metformin by tissues of the normal and diabetic mouse | Q72381698 | ||
| Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus | Q72583835 | ||
| Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine | Q73551272 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2015-12-14 | |
| P1433 | published in | Behavioural Brain Research | Q3619047 |
| P1476 | title | Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice | |
| P478 | volume | 301 |
| Q57167377 | A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup |
| Q92503915 | A toolbox for the longitudinal assessment of healthspan in aging mice |
| Q43373021 | Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus |
| Q33624944 | Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels-An Ex Vivo Study. |
| Q89005064 | Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging |
| Q29994589 | Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential |
| Q64230757 | Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus |
| Q92587931 | Development of Clinical Trials to Extend Healthy Lifespan |
| Q37693354 | Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease. |
| Q97644112 | Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network |
| Q38673914 | Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla |
| Q37619208 | Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice |
| Q92387294 | Metformin and cognition from the perspectives of sex, age, and disease |
| Q38865781 | Metformin as a Tool to Target Aging |
| Q47643213 | Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression |
| Q47866309 | Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer's Disease: Are There Methodological Biases? |
| Q38926789 | Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes |
| Q51760982 | Sirtuins as Mediator of the Anti-Ageing Effects of Calorie Restriction in Skeletal and Cardiac Muscle. |
| Q42334472 | The Neuroprotective Effects of Muscle-Derived Stem Cells via Brain-Derived Neurotrophic Factor in Spinal Cord Injury Model |
| Q57175337 | The Therapeutic Potential of Metformin in Neurodegenerative Diseases |
| Q89937434 | The road ahead for health and lifespan interventions |
| Q48470200 | Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway |
Search more.